SC 13G/A | 2023-02-13 | Parkman Healthcare Partners LLC | PLUS THERAPEUTICS, INC. | 583,467 | 1.7% | EDGAR |
SC 13G/A | 2022-02-11 | INTRACOASTAL CAPITAL, LLC | PLUS THERAPEUTICS, INC. | 300,000 | 1.9% | EDGAR |
SC 13G/A | 2022-02-04 | Hudson Bay Capital Management LP | PLUS THERAPEUTICS, INC. | 550,000 | 3.5% | EDGAR |
SC 13G | 2022-02-04 | Parkman Healthcare Partners LLC | PLUS THERAPEUTICS, INC. | 1,508,508 | 7.4% | EDGAR |
SC 13G/A | 2021-02-26 | NanoTx, Corp. | PLUS THERAPEUTICS, INC. | 230,769 | 4.8% | EDGAR |
SC 13G/A | 2021-02-26 | NanoTx, Corp. | PLUS THERAPEUTICS, INC. | 230,769 | 4.8% | EDGAR |
SC 13G/A | 2021-02-10 | Hudson Bay Capital Management LP | PLUS THERAPEUTICS, INC. | 530,474 | 10.0% | EDGAR |
SC 13G/A | 2021-01-29 | INTRACOASTAL CAPITAL, LLC | PLUS THERAPEUTICS, INC. | 300,000 | 5.9% | EDGAR |
SC 13G | 2020-05-14 | NanoTx, Corp. | PLUS THERAPEUTICS, INC. | 230,769 | 5.6% | EDGAR |
SC 13G/A | 2020-02-14 | Anson Funds Management LP | PLUS THERAPEUTICS, INC. | 198,034 | 4.9% | EDGAR |
SC 13G/A | 2020-02-14 | Sassicaia Capital Advisers LLC | PLUS THERAPEUTICS, INC. | 3,798 | 0.1% | EDGAR |
SC 13G/A | 2020-02-11 | INTRACOASTAL CAPITAL, LLC | PLUS THERAPEUTICS, INC. | 405,584 | 10.0% | EDGAR |
SC 13G | 2020-02-07 | Hudson Bay Capital Management LP | PLUS THERAPEUTICS, INC. | 418,488 | 10.0% | EDGAR |
SC 13G | 2019-10-07 | INTRACOASTAL CAPITAL, LLC | PLUS THERAPEUTICS, INC. | 127,005 | 10.0% | EDGAR |
SC 13G | 2019-10-03 | ARMISTICE CAPITAL, LLC | PLUS THERAPEUTICS, INC. | 61,427 | 5.0% | EDGAR |
SC 13G | 2019-09-27 | Anson Funds Management LP | PLUS THERAPEUTICS, INC. | 369,379 | 9.9% | EDGAR |
SC 13G | 2019-08-26 | Sassicaia Capital Advisers LLC | PLUS THERAPEUTICS, INC. | 1,200 | 0.3% | EDGAR |
SC 13G/A | 2018-08-28 | Swissquote Bank SA | CYTORI THERAPEUTICS, INC. | 376,723 | 4.9% | EDGAR |
SC 13G/A | 2018-05-24 | PostFinance AG | CYTORI THERAPEUTICS, INC. | 2,795,561 | 4.5% | EDGAR |
SC 13G/A | 2018-04-10 | PostFinance AG | CYTORI THERAPEUTICS, INC. | 3,609,685 | 5.9% | EDGAR |